Information platform for Japanese Medicines

GlashVista cutaneous solution 0.03% 5mL

Tags
Different Standards/Packaging Product
  • Discontinued
Log in or Sign up required.
Detailed information
Branded Name
GlashVista cutaneous solution 0.03% 5mL
Generic Name
Bimatoprost
Heat Number / Carved Seal
N/A
Form / Color
- / -
Ministry of Health and Welfare Code
N/A
YJ Code
267970AQ1020
Manufacturer
Allergan Aesthetics as AbbVie company
MA holder
Allergan Aesthetics as AbbVie company
Restriction Information
-
Storage Condition
-
Cautions for Storage
-
Brand / Authorized Generic / Generic
Brand
Biological Origin / Biosimilar
No
Strength
0.03 %
Prescription Drug
Yes
Followed by Generic
not available
Effective date
000 00, 0000
Lot No.
00000000
Lead time
X days
Created at
Updated at
Log in or Sign up required.
Branded Name
GlashVista cutaneous solution 0.03% 5mL
Generic Name
Bimatoprost
Heat Number / Carved Seal
N/A
Form / Color
- / -
Ministry of Health and Welfare Code
N/A
YJ Code
267970AQ1020
Manufacturer
Allergan Aesthetics as AbbVie company
MA holder
Shionogi Pharma Co., Ltd
Restriction Information
-
Storage Condition
-
Cautions for Storage
-
Brand / Authorized Generic / Generic
Brand
Biological Origin / Biosimilar
No
Strength
0.03 %
Prescription Drug
Yes
Followed by Generic
not available
Effective date
000 00, 0000
Lot No.
00000000
Lead time
X days
Created at
Updated at
Log in or Sign up required.

Japanese notation

Product Name
グラッシュビスタ外用液剤0.03%5mL
Name of Manufacturer
アッヴィ
Name of MA Holder
塩野義製薬、アッヴィ
Form / Color
液 / 無色澄明

Alternative pharmaceuticals

*About alternative pharmaceuticals...This information is based on the active ingredients, dosage form, and specifications/units. It does not necessarily mean that the product is currently available.

No alternative pharmaceuticals found.
the English trade name

This website is available exclusively to healthcare professionals outside of Japan.

Registration and use by the general public are not permitted. Upon member registration, we will verify your credentials related to pharmaceutical transactions.

Are you a healthcare professional outside of Japan?